The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Nutrients · 15.08.2023 · 15 (16) · 3585
DOI: 10.3390/nu15163585 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 15.08.2023. Verfasst von Viviana A Ruiz-Pozo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador. Hauptthemen laut MEDLINE: Parkinson Disease, Insulin Resistance, Insulins. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad UTE.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a degenerative condition resulting from the loss of dopaminergic neurons. This neuronal loss leads to motor and non-motor neurological symptoms. Most PD cases are idiopathic, and no cure is available. Recently, it has been proposed that insulin resistance (IR) could be a central factor in PD development. IR has been associated with PD neuropathological features like α-synuclein aggregation, dopaminergic neuronal loss, neuroinflammation, mitochondrial dysfunction, and autophagy. These features are related to impaired neurological metabolism, neuronal death, and the aggravation of PD symptoms. Moreover, pharmacological options that involve insulin signaling improvement and dopaminergic and non-dopaminergic strategies have been under development. These drugs could prevent the metabolic pathways involved in neuronal damage. All these approaches could improve PD outcomes. Also, new biomarker identification may allow for an earlier PD diagnosis in high-risk individuals. This review describes the main pathways implicated in PD development involving IR. Also, it presents several therapeutic options that are directed at insulin signaling improvement and could be used in PD treatment. The understanding of IR molecular mechanisms involved in neurodegenerative development could enhance PD therapeutic options and diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.
- School of Medicine, Universidad Católica Santiago de Guayaquil, Guayaquil 090615, Ecuador.
- Departamento de Bioquímica, Facultad de Ciencias Médicas, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1121ABE, Argentina.
- Equipo de Soporte Nutricional, Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires C1280AEB, Argentina.
- School of Medicine, Universidad Espíritu Santo, Samborondón 091952, Ecuador.
- Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.
ORCID-Profile: Viviana A Ruiz-Pozo, Rafael Tamayo-Trujillo, Santiago Cadena-Ullauri, Evelyn Frias-Toral, Patricia Guevara-Ramírez, Ana Karina Zambrano
Förderung
- Universidad UTE
Zitieren
APA
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., & Zambrano, A. K. (2023). The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis. Nutrients, 15(16), 3585. https://doi.org/10.3390/nu15163585
Vancouver
Ruiz-Pozo VA, Tamayo-Trujillo R, Cadena-Ullauri S, Frias-Toral E, Guevara-Ramírez P, Paz-Cruz E, et al. The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis. Nutrients. 2023;15(16):3585. doi:10.3390/nu15163585
BibTeX
@article{RuizPozo2023,
author = {Ruiz-Pozo, Viviana A and Tamayo-Trujillo, Rafael and Cadena-Ullauri, Santiago and Frias-Toral, Evelyn and Guevara-Ramírez, Patricia and Paz-Cruz, Elius and Chapela, Sebastián and Montalván, Martha and Morales-López, Tania and Simancas-Racines, Daniel and Zambrano, Ana Karina},
title = {The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {16},
pages = {3585},
doi = {10.3390/nu15163585}
}
EUVIMED